Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Abstract Psoriasis is now considered a systemic disease, and several comorbidities have been described such as cardiovascular diseases, neurologic and psychiatric disorders, chronic inflammatory bowel disease, psoriatic arthritis, etc. Regarding cardiovascular comorbidities, major adverse cardiovasc...
Saved in:
Main Authors: | Luca Potestio (Author), Nello Tommasino (Author), Giuseppe Lauletta (Author), Fabrizio Martora (Author), Matteo Megna (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Use of Photodynamic Therapy for Treatment of Palbociclib-Induced Periorificial Dermatitis
by: Davide Fattore, et al.
Published: (2024) -
Risk Factors for Psoriasis Flares: A Narrative Review
by: Potestio L, et al.
Published: (2024) -
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
by: Potestio L, et al.
Published: (2024) -
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
by: Martora F, et al.
Published: (2024) -
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
by: Potestio L, et al.
Published: (2023)